Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 26, 2016 - Issue 1
Submit an article Journal homepage
833
Views
53
CrossRef citations to date
0
Altmetric
Reviews

15-Lipoxygenase inhibitors: a patent review

Hamid SadeghianNeurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran;Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad91857-63788, IranCorrespondence[email protected]
&
Atena JabbariDepartment of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
Pages 65-88 | Published online: 11 Nov 2015

Bibliography

  • Papers of special note have been highlighted as either of interest (•) or of considerable interest (••) to readers.
  • Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1992;1128:117–131.
  • Fürstenberger G, Krieg P, Müller-Decker K, et al. What are cyclooxygenases and lipoxygenases doing in the driver’s seat of carcinogenesis? Int J Cancer. 2006;119:2247–2254.
  • Kuhn H, Walther M, Kuban RJ. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 2002;68–69:263–290.
  • Kuhn H, Thiele BJ. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett. 1999;449:7–11.
  • Kühn H, Barnett J, Grunberger D, et al. Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta. 1993;1169:80–89.
  • Kühn H, Thiele BJ, Ostareck-Lederer A, et al. Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase. Biochim Biophys Acta. 1993;1168:73–78.
  • Brash AR, Boeglin WE, Chang MS. Discovery of a second 15-lipoxygenase in humans. Proc Natl Acad Sci USA. 1997;94:6148–6152.
  • Grüllich C, Duvoisin RM, Wiedmann M, et al. Inhibition of 15-lipoxygenase leads to delayed organelle degradation in the reticulocyte. FEBS Lett. 2001;489:51–54.
  • Kroschwald P, Kroschwald A, Kühn H, et al. Occurrence of the erythroid cell-specific arachidonate 15-lipoxygenase in human reticulocytes. Biochem Biophys Res Commun. 1989;160:954–960.
  • Vijayvergiya C, De Angelis D, Walther M, et al. High-level expression of rabbit 15-lipoxygenase induces collapse of the mitochondrial pH gradient in cell culture. Biochemistry. 2004;43:15296–15302.
  • Maccarrone M, Melino G, Finazzi-Agrò A. Lipoxygenases and their involvement in programmed cell death. Cell Death Differ. 2001;8:776–784.
  • Nadel JA, Conrad DJ, Ueki IF, et al. Immunocytochemical localization of arachidonate 15-lipoxygenase in erythrocytes, leukocytes, and airway cells. J Clin Invest. 1991;87:1139–1145.
  • Van Leyen K, Duvoisin RM, Engelhardt H, et al. A function for lipoxygenase in programmed organelle degradation. Nature. 1998;395:392–395.
  • Yokota S, Oda T, Fahimi HD. The role of 15-lipoxygenase in disruption of the peroxisomal membrane and in programmed degradation of peroxisomes in normal rat liver. J Histochem Cytochem. 2001;49:613–622.
  • Kilty I, Logan A, Vickers PJ. Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15-lipoxygenase. Eur J Biochem. 1999;266:83–93.
  • Feltenmark S, Gautam N, Brunnström A, et al. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci USA. 2008;105:680–685.

• 15-LOX-1 is a target for reducing the biosynthesis of eoxines, one of the known proinflammatory mediators.

  • Jeon SG, Moon HG, Kim YS, et al. 15-Lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA. Clin Exp Allergy. 2009;39:908–917.
  • Zhao J, O’Donnell VB, Balzar S, et al. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells. Proc Natl Acad Sci USA. 2011;108:14246–14251.
  • Spindler SA, Sarkar FH, Sakr WA, et al. Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun. 1997;239:775–781.
  • Kelavkar UP, Cohen C, Kamitani H, et al. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis. 2000;21:1777–1787.
  • Kelavkar U, Lin Y, Landsittel D, et al. The yin and yang of 15-lipoxygenase-1 and delta-desaturases: dietary omega-6 linoleic acid metabolic pathway in prostate. J Carcinog. 2006;5:9.
  • Kelavkar UP, Glasgow W, Olson SJ, et al. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia. 2004;6:821–830.
  • Kelavkar UP, Parwani AV, Shappell SB, et al. Conditional expression of human 15- lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia. 2006;8:510–522.

• Demonstrates the critical role of the 15-LOX-1 metabolite 13-(S)-hydroxyoctadecadienoic acid (13-HODE) in the progression of prostate cancers and the inhibition of 15-LOX-1 activity for apoptosis induction in PC3 cells.

  • Sen M, McHugh K, Hutzley J, et al. Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions. Prostaglandins Other Lipid Mediat. 2006;81:1–13.
  • Kelavkar UP, Nixon JB, Cohen C, et al. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis. 2001;22:1765–1773.
  • Kelavkar UP, Harya NS, Hutzley J, et al. DNA methylation paradigm shift: 15- lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Prostaglandins Other Lipid Mediat. 2007;82:185–197.
  • Das S, Roth CP, Wasson LM, et al. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Prostate. 2007;67:1550–1564.
  • Belkner J, Stender H, Kühn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E. J Biol Chem. 1998;273:23225–23232.
  • Belkner J, Wiesner R, Rathman J, et al. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur J Biochem. 1993;213:251–261.
  • Heydeck D, Upston JM, Viita H, et al. Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions. J Lipid Res. 2001;42:1082–1088.
  • Benz DJ, Mol M, Ezaki M, et al. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J Biol Chem. 1995;270:5191–5197.
  • Huo Y, Zhao L, Hyman MC, et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;110:2024–2031.
  • Hugou I, Blin P, Henri J, et al. 15-Lipoxygenase expression in smooth muscle cells from atherosclerotic rabbit aortas. Atherosclerosis. 1995;113:189–195.
  • Hiltunen T, Luoma J, Nikkari T, et al. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation. 1995;92:3297–3303.
  • Kühn H, Heydeck D, Hugou I, et al. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest. 1997;99:888–893.
  • Ravalli S, Marboe CC, D’Agati VD, et al. Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:340348.
  • Ylä-Herttuala S, Luoma J, Viita H, et al. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest. 1995;95:2692–2698.
  • Bocan TM, Rosebury WS, Mueller SB, et al. A specific 15-lipoxygenase inhibitor limits the progression and monocyte-macrophage enrichment of hypercholesterolemia-induced atherosclerosis in the rabbit. Atherosclerosis. 1998;136:203–216.
  • Van Leyen K, Holman TR, Lo EH, et al. Novel lipoxygenase inhibitors as neuroprotective agents. US 2012/0053220 A1.

• Shows the role of oxidative stress in a variety of neurodegenerative diseases, including stroke, Alzheimer’s disease and Parkinson’s disease.

  • Van Leyen K, Kim HY, Lee SR, et al. Biacalein and 12/15- lipoxygenase in the ischemic brain. Stroke. 2006;37:3014–3018.
  • Mytilineous C, Kramer BC, Yabut JA. Glutathion depletion and oxidative stress. Parkinsonism Relat Disord. 2002;8:385–387.
  • Boddupalli S, Leibowitz DN, Miller G. Methods for treating diabetes. US 2006/0106014 A1.
  • Martin G, Barradeau S, Sayah-Jeanne S. Use of 15-lipoxygenase inhibitors for treating obesity. US 8,048,900 B2.

•• Shows positive effect of PD146176 in controlling obesity

  • Nadler JL, Taylor-Fishwick D, Chakrabarti S, et al. Treatment of diabetes and disorders associated with viscerar obesity with inhibitors of human arachidonate 12-lipoxygenase and arachidonate 15-lipoxygenase. WO 2011/088322 A1.
  • Brathe A, Andresen G, Gundersen LL, et al. Antioxidant activity of synthetic cytokinin analogues: 6-alkynyl- and 6-alkenylpurines as novel 15-lipoxygenase inhibitors. Bioorg Med Chem. 2002;10:1581–1586.
  • Da Silva EL, Tsushida T, Terao J. Inhibition of mammalian 15-lipoxygenase-dependent lipid peroxidation in low-density lipoprotein by quercetin and quercetin monoglucosides. Arch Biochem Biophys. 1998;349:313.
  • Lyckander JM, Malterud KE. Lipophilic flavonoids from Ortosiphon spicatus as inhibitors of 15-lipoxygenase. Acta Pharm Nord. 1992;4:159–166.
  • Malterud KE, Rydland KM, Haugli T. Inhibtion of 15-lipoxygenase by phthalate plasticizers. Bull Environ Contam Toxicol. 1999;62:352–355.
  • Brathe A, Gundersen LL, Malterud KE, et al. 6-Substituted purines as inhibitors of 15-lipoxygenase; a structure-activity study. Arch Pharm Chem Life Sci. 2005;338:159−166.
  • Berg TC, Gundersen LL, Eriksen AB, et al. Synthesis of optically active 6-alkynyl- and 6-alkylpurines as cytokinin analogs and inhibitors of 15-lipoxygenase; studies of intramolecular cyclization of 6-(hydroxyalkyn-1-yl)purines. Eur J Org Chem. 2005;2005:4988–4994.
  • Nasir AI, Gundersen LL, Rise F, et al. Inhibition of lipid peroxidation mediated by indolizines. Bioorg Med Chem Lett. 1998;8:1829.
  • Østby OB, Dalhus B, Gundersen LL, et al. Synthesis of 1-substituted 7-cyano-2,3-diphenylindolizines and evaluation of antioxidant properties. Eur J Org Chem. 2000;9:3763.
  • Gundersen LL, Malterud KE, Negussie AH, et al. Indolizines as novel potent inhibitors of 15-lipoxygenase. Bioorg Med Chem. 2003;11:5409–5415.
  • Teklu S, Gundersen LL, Larsen T, et al. Indolizine 1-sulfonates as potent inhibitors of 15-lipoxygenase from soybeans. Bioorg Med Chem. 2005;13:3127–3139.
  • Young TE, Scott PH. Benz[b]indolo[2,3-d] thiopyrylium compounds and processes for their production. US 3,388,133.
  • Petitpierre JC. Production of chromenoindole compounds. US 4,132,714.
  • Bair KW. Benzo[c] carbazole propanediol compound and salts thereof. US 4,797,495.
  • Widdig A, Kühle E, Grewe F, et al. 1-Amino-sulfonyl-2-amino benzimidazoles. US 3,853,908.
  • Actor PP, Pagano JF. 5(6)-N-butyl-2-carbomethoxy-benzimidazole. US 3,682,952.
  • Cornicelli JA, Padia JK, Lane Y, et al. Method for treating and preventing inflammation and atherosclerosis. WO 97/12613.
  • Weinstein DS, Liu W, Gu Z, et al. Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase. Bioorg Med Chem Lett. 2005;15:1435–1440.
  • Connor DT, Roark WH, Sorenson RJ. Indole and benzimidazole 15- lipoxygenase inhibitors. US 6,858,739 B2.
  • Lin BB, Morita T, Lin YS, et al. A facile synthesis of 1-ethoxy-4-cyano-5-ethoxycarbonyl-3Hazuleno[1,2-c]pyran-3-one, a selective 15-lipoxygenase inhibitor. Bioorg Med Chem Lett. 2004;14:63–65.
  • Lin BB, Lin YS. One-pot synthesis and evaluation for 15-lipoxygenase inhibition of 1-ethoxy-4-cyano-5-ethoxycarbonyl-3H-azuleno[1,2-c]pyran3-imine. J Heterocyclic Chem. 2011;48:205–208.
  • Trivedi B, Roth BD, Padia JK. Benzimidazol derivatives as 15-LOX inhibitors. WO 97/12615.
  • Picard JA, Roark WH, Sliskovic DR. 5,6-Fussed bicyclic heterocycles. WO 01/96336.
  • Weinstein DS, Liu W, Ngu K, et al. Discovery of selective imidazole-based inhibitors of mammalian 15-lipoxygenase: highly potent against human enzyme within a cellular environment. Bioorg Med Chem Lett. 2007;17:5115–5120.
  • Assadieskandar A, Amini M, Salehi M, et al. Synthesis and SAR study of 4,5-diaryl-1H-imidazole-2(3H)-thione derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2012;20:7160–7166.
  • Bakavoli M, Nikpour M, Rahimizadeh M, et al. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2007;15:2120–2126.
  • Nikpour M, Mousavian M, Davoodnejad M, et al. Synthesis of new series of pyrimido[4,5-b][1,4] benzothiazines as 15-lipoxygenase inhibitors and study of their inhibitory mechanism. Med Chem Res. 2013;22:5036–5043.
  • Hallberg A, Schaul W, Larhed M, et al. Pyrazol compounds useful in the treatment of inflammation. WO 2004/080999.
  • Ngu K, Weinstein DS, Liu W, et al. Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase. Bioorg Med Chem Lett. 2011;21:4141–4145.
  • Rai G, Kenyon V, Jadhav A, et al. Discovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1. J Med Chem. 2010;53:7392–7404.
  • Tehrani MB, Emami S, Asadi M, et al. Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase. Euro J Med Chem. 2014;87:759–764.
  • Weinstein DS. Inhibitors of 15-lipoxygenase. US 2005/0065198A1.
  • Rai G, Joshi N, Jung JE, et al. Potent and selective inhibitors of human reticulocyte 12/15- lipoxygenase as anti-stroke therapies. J Med Chem. 2014;57:4035–4048.
  • Pelcman B, Sanin A, Nilsson P, et al. Triazole compounds as lipoxygenase inhibitors. US 2009/0186918 A1.
  • Bolton G, Domagala JM, Elslager EF, et al. Isothiazolones. WO 96/38144.
  • Tiat BD, Dyer RD, Auerbach BJ, et al. Catechol-based inhibitors of 15-lipoxygenase. Bioorg Med Chem Lett. 1996;6:93–96.
  • Simpson J, Forrester R, Tisdale MJ, et al. Effect of catechol derivatives on cell growth and lipoxygenase activity. Bioorg Med Chem Lett. 2003;13:2435–2439.
  • Whitman S, Gezginci M, Timmermann BN, et al. Structure–activity relationship studies of nordihydroguaiaretic acid inhibitors toward soybean, 12-human, and 15-human lipoxygenase. J Med Chem. 2002;45:2659–2661.
  • Malterud KE, Ryland KM. Inhibitors of 15-lipoxygenase from orange peel. J Agric Food Chem. 2000;48:5576–5580.
  • Schewe T, Sadik C, Klotz LO, et al. Polyphenols of cocoa: inhibition of mammalian 15-lipoxygenase. Biol Chem. 2001;382:1687–1696.
  • Wangensteen H, Miron A, Alamgir M, et al. Antioxidant and 15-lipoxygenase inhibitory activity of rotenoids, isoflavones and phenolic glycosides from Sarcolobus globosus. Fitoterapia. 2006;77:290–295.
  • Vasquez-Martinez Y, Ohri RV, Kenyon VA, et al. Structure–activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. Bioorg Med Chem. 2007;15:7408–7425.
  • Togola A, Heddind B, Theis A, et al. 15-Lipoxygenase inhibitory effects of prenylated flavonoids from Erythrina senegalensis. Planta Med. 2009;75:1168–1170.
  • Malterud KE, Farbrot TL, Huse AE, et al. Antioxidant and radical scavenging of anthraquinones and anthrones. Pharmacology. 1993;47:77–85.
  • Carroll J, Jonsson EN, Ebel R, et al. Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitors. J Org Chem. 2001;66:6847–6851.
  • Kerr RG, Kerr SS. Marine natural products as therapeutic agents. Exper Opin Ther Pat. 1999;9:1207–1222.
  • Fu X, Schmitz FJ, Govindan M, et al. Enzyme inhibitors: new and known polybrominated phenols and diphenyl ethers from four Indo-Pacific Dysidea sponges. J Nat Prod. 1995;58:1384–1391.
  • Amagata T, Whitman S, Johnson TA, et al. Exploring sponge-derived terpenoids for their potency and selectivity against 12-human, 15-human, and 15-soybean lipoxygenases. J Nat Prod. 2003;66:230–235.
  • Segraves EN, Shah RR, Segraves NL, et al. Probing the activity differences of simple and complex brominated aryl compounds against 15-soybean, 15-human, and 12-human lipoxygenase. J Med Chem. 2004;47:4060–4065.
  • Cichewicz RH, Kenyon VA, Whitman S, et al. Redox inactivation of human 15-lipoxygenase by marine-derived meroditerpenes and synthetic chromanes: archetypes for a unique class of selective and recyclable inhibitors. J Am Chem Soc. 2004;126:14910–14920.
  • Russell W, Scobbie L, Duthie GG, et al. Inhibition of 15-lipoxygenase-catalysed oxygenation of arachidonic acid by substituted benzoic acids. Bioorg Med Chem. 2008;16:4589–4593.
  • Takeda S, Jianj R, Aramaki H, et al. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors. J Pharm Sci. 2011;100:1206–1211.
  • Sadeghian H, Seyedi SM, Saberi MR, et al. Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2008;16:890–901.
  • Horchani H, Ben Salem N, Sayari ZA, et al. Enzymatic synthesis of eugenol benzoate by immobilized Staphylococcus aureus lipase: optimization using response surface methodology and determination of antioxidant activity. Bioresource Tech. 2010;101:2809–2817.
  • Sadeghian H, Attaran N, Jafari Z, et al. Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem. 2009;17:2327–2335.
  • Sadeghian H, Seyedi SM, Attaran N, et al. Synthesis and SAR comparative studies of 2-allyl-4-methoxy-1-alkoxybenzenes as 15-lipoxygenase inhibitors. J Enzym Inhib Med Chem. 2011;26:238–244.
  • Seyedi SM, Jafari Z, Attaran N, et al. Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors. Bioorg Med Chem. 2009;17:1614–1622.
  • Jabbari A, Davoodnejad M, Alimardani M, et al. Synthesis and SAR studies of novel 3-allyl-4-prenyloxyanilline amides as potent 15-lipoxygenase inhibitors. Bioorg Med Chem. 2012;20:5518–5526.
  • Yang LX, Huang KX, Li HB, et al. Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives. J Med Chem. 2009;52:7732–7752.
  • Iranshahi M, Jabbari A, Orafaie A, et al. Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors. Euro J Med Chem. 2012;57:134–142.
  • Hampson AJ, Axelrod J, Grimaldi M. Cannabinoids as antioxidant and neuroprotectants. US 6,630,507 B1.
  • Blecha JE, Anderson MO, Chow JM, et al. Inhibition of IGF-IR and lipoxygenase by nordihydroguaretic acid (NDGA) analogs. Bioorg Med Chem Lett. 2007;17:4026–4029.
  • Takeda S, Usami N, Yamamoto I, et al. Cannabidiol-2ʹ,6ʹ-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitors. Drug Metab Dispos. 2009;37:1733–1737.

•• Shows the selectivity of CBDD (dimethyl cannabidiol) in comparison with CBD (cannabidiol) for 15-LOX-1 inhibition.

  • Borel C, Wetti DH, Fernandez I, et al. An antimicrobial and 15-lipoxygenase inhibitor from the moss Dicranum scoparium. J Nat Prod. 1993;56:1071–1073.
  • Jacquot C, McGinley CM, Plata E, et al. Synthesis of 11-thialinoleic acid and 14-thialinoleic acid, inhibitors of soybean and human lipoxygenase. Org Biomol Chem. 2008;6:4242–4252.
  • Connor DT, Roark WH, Sorenson RJ. Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis. WO 99/32433.
  • Barvian NC, Oʼbrian PM, Patt WC, et al. 1,2,4-trisubstituted benzene as inhibitors of 15-lipoxygenase. WO 01/96298A2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.